ATRA - Atara Biotherapeutics Inc logo

ATRA

Atara Biotherapeutics Inc

Rev —top 1%10Y
Hold

Atara Biotherapeutics develops T-cell immunotherapies for cancer and autoimmune diseases, focusing on treatments like Tab-cel for EBV-related conditions and ATA3219 for B-cell malignancies. It partners with research institutions for collaborative studies.

⚕️ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago $17today

Score Overview

1 Year
Score
Net Growth-128.96%
Net TrendShrank
Net Income Consistency
Rev Growth-80.84%
Rev TrendShrank
Revenue Consistency
5 Years
Score5.2
Net Growth97.22%
Net Trend60%
Net Income Consistency
Rev Growth13.76%
Rev Trend40%
Revenue Consistency
10 Years
Score
Net Growth88.02%
Net Trend30%
Net Income Consistency
Rev Growth
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth66.20%
Net Trend25%
Net Income Consistency
Rev Growth
Rev Trend33%
Revenue Consistency

See the full market ranking →

Atara Biotherapeutics Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 3M to $ 120M and net income went from -$ 306M to $ 32M. Revenue increased in 2 of those 5 years; net income in 3.

Atara Biotherapeutics Inc currently holds a 5-year HDB Score of 5.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 9.22
1 Year2025-08-12
$ 11.54-20.06%
5 Years2021-08-12
$ 314.00-97.06%
10 Years2016-08-12
$ 530.50-98.26%
All Time2014-10-16
$ 266.25-96.54%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 23M-$ 9M$ 8M
2025$ 120M$ 32M$ 8M
2024$ 128M-$ 85M$ 42M
2023$ 8M-$ 276M$ 51M
2022$ 63M-$ 228M$ 242M
2021$ 20M-$ 340M$ 371M
2020$ 3M-$ 306M$ 500M
2019$ 0.00-$ 290M$ 259M
2018$ 0.00-$ 230M$ 309M
2017$ 0.00-$ 119M$ 166M
2016$ 0.00-$ 79M$ 255M
2015$ 0.00-$ 57M$ 320M
IPO2014$ 0.00-$ 28M$ 104M

Explore beyond ATRA

You're looking at Atara Biotherapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies